Harold Eugene Brakewood insider trades

Open-market stock purchases and sales by Harold Eugene Brakewood, Chief Business Officer at Immuneering Corp, from SEC Form 4 filings since Mar 31, 2023.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +54%.

Recent trades

DateStockTradeValue
Feb 3, 2026IMRX Immuneering CorpBought (not open market)—
Jan 16, 2026IMRX Immuneering CorpBought$25K

Companies traded

  • IMRX Immuneering Corp: 3 buys, last Feb 3, 2026

Get free alerts when Harold Eugene Brakewood files a new trade →